Equivalent humoral and cellular immune response but different side effect rates following SARS-CoV-2 vaccination in peritoneal and haemodialysis patients using messenger RNA vaccines

Research output: Contribution to journal › Research article › Contributed › peer-review

Contributors

Julian Stumpf - , Department of Internal Medicine III, KfH Dialysis Center Dresden (Author)
Anna Klimova - , National Center for Tumor Diseases (NCT) Dresden (Author)
René Mauer - , Institute for Medical Informatics and Biometry (Author)
Anne Steglich - , Department of Internal Medicine III (Author)
Florian Gembardt - , Department of Internal Medicine III (Author)
Heike Martin - , Nephrologisches Zentrum Zwickau (Author)
Grit Glombig - , St. Georg Hospital Leipzig (Author)
Kerstin Frank - , DRK Blutspendendienst Nord Ost gGmbH (Author)
Torsten Tonn - , Department of Internal Medicine I, Division Transfusion Medicine, DRK Blutspendendienst Nord Ost gGmbH (Author)
Christian Hugo - , Department of Internal Medicine III, KfH Dialysis Center Dresden (Author)

Original language	English
Pages (from-to)	796-798
Number of pages	3
Journal	Nephrology Dialysis Transplantation
Volume	37
Issue number	4
Publication status	Published - 25 Mar 2022
Peer-reviewed	Yes

COVID-19/prevention & control, COVID-19 Vaccines/adverse effects, Humans, Immunity, Cellular, Renal Dialysis/adverse effects, SARS-CoV-2, Vaccination/adverse effects, mRNA Vaccines